SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 42 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $231,000 | +59.3% | 116,246 | 0.0% | 0.01% | +50.0% |
| Q3 2020 | $145,000 | -52.6% | 116,246 | -90.0% | 0.01% | -55.6% |
| Q2 2020 | $306,000 | -36.5% | 1,162,473 | 0.0% | 0.02% | -55.0% |
| Q1 2020 | $482,000 | +22.6% | 1,162,473 | 0.0% | 0.04% | +81.8% |
| Q4 2019 | $393,000 | -53.0% | 1,162,473 | 0.0% | 0.02% | -60.7% |
| Q3 2019 | $837,000 | -0.9% | 1,162,473 | 0.0% | 0.06% | +36.6% |
| Q2 2019 | $845,000 | -40.2% | 1,162,473 | 0.0% | 0.04% | -30.5% |
| Q1 2019 | $1,412,000 | +192.3% | 1,162,473 | 0.0% | 0.06% | +126.9% |
| Q4 2018 | $483,000 | -79.2% | 1,162,473 | 0.0% | 0.03% | -72.3% |
| Q3 2018 | $2,325,000 | -5.6% | 1,162,473 | 0.0% | 0.09% | -4.1% |
| Q2 2018 | $2,464,000 | -22.1% | 1,162,473 | 0.0% | 0.10% | -27.4% |
| Q1 2018 | $3,162,000 | -26.3% | 1,162,473 | 0.0% | 0.14% | -27.0% |
| Q4 2017 | $4,290,000 | +90.2% | 1,162,473 | 0.0% | 0.18% | +94.7% |
| Q3 2017 | $2,255,000 | -28.2% | 1,162,473 | 0.0% | 0.10% | -35.4% |
| Q2 2017 | $3,139,000 | -34.1% | 1,162,473 | 0.0% | 0.15% | -34.7% |
| Q1 2017 | $4,766,000 | +13.3% | 1,162,473 | 0.0% | 0.22% | -6.2% |
| Q4 2016 | $4,208,000 | -17.2% | 1,162,473 | 0.0% | 0.24% | -18.6% |
| Q3 2016 | $5,080,000 | – | 1,162,473 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|